...
首页> 外文期刊>Biotechnology Law Report >A Small Detail in the Specification May Save 'Molecular Weight'' from Being Held Indefinite: A Lesson from Reckitt Benckiser Pharm. Inc. v. Watson Labs., Inc.
【24h】

A Small Detail in the Specification May Save 'Molecular Weight'' from Being Held Indefinite: A Lesson from Reckitt Benckiser Pharm. Inc. v. Watson Labs., Inc.

机译:该规范中的一个小细节可以挽救“分子量”被持有的无限期:来自Reckitt Benckiser Pharm的课程。Inc.V.VATSON LABS。,Inc。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Teva Pharms. USA, Inc. v. Sandoz, Inc., 789 F.3d 1335 (Fed. Cir. 2015), indicates that "molecular weight'' may be an indefinite claim term for polymer-related claims if the specification fails to provide the definition of "molecular weight.'' Since Teva Pharms. USA, Inc., whether "molecular weight'' is an indefinite claim term has become an issue in litigation concerning polymer-related patents. This article reports Reckitt Benckiser Pharm. Inc. v. Watson Labs., Inc., No. CV 13-1674-RGA, 2016 WL 3186659 (D. Del. June 3, 2016), where the court relied on a footnote of one table in the specification to hold the disputed term "molecular weight'' definite. Such footnote merely disclosed the name of the company that manufactured the claimed polymer related to the dispute term. This article argues that while a small detail in the specification may save "molecular weight'' from being held indefinite, it is better to disclose the molecular weight definition provided by the manufacturer.
机译:Teva Pharms。 美国,Inc.V.Sandoz,Inc。,789 F.3D 1335(CIR。CIR。2015),表示“分子量”可以是与聚合物相关权利要求的无限索赔术语,如果规范未能提供定义 自Teva Pharms以来“分子量”。 美国,Inc。,无论是“分子量”是无限期的索赔术语已成为诉讼中有关聚合物相关专利的问题。本文报告了Reckitt Benckiser Pharm.Inc.V.V.Watson Labs。,Inc.,No. CV 13 -1674-RGA,2016 WL 3186659(D.Del。2016年6月3日),法院在规范中依靠一张表的脚注,以举行有争议的术语“分子量”的确定。 这种脚注仅披露了制造与争议术语相关的所要求保护的聚合物的公司名称。 本文认为,虽然说明书中的一个小细节可以保存“分子量”被保持无限制,但最好是公开制造商提供的分子量定义。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号